Literature DB >> 17312186

Open channel block of A-type, kv4.3, and delayed rectifier K+ channels, Kv1.3 and Kv3.1, by sibutramine.

Sung Eun Kim1, Hye Sook Ahn, Bok Hee Choi, Hyun-Jong Jang, Myung-Jun Kim, Duck-Joo Rhie, Shin-Hee Yoon, Yang-Hyeok Jo, Myung-Suk Kim, Ki-Wug Sung, Sang June Hahn.   

Abstract

The effects of sibutramine on voltage-gated K+ channel (Kv)4.3, Kv1.3, and Kv3.1, stably expressed in Chinese hamster ovary cells, were investigated using the whole-cell patch-clamp technique. Sibutramine did not significantly decrease the peak Kv4.3 currents, but it accelerated the rate of decay of current inactivation in a concentration-dependent manner. This phenomenon was effectively characterized by integrating the total current over the duration of a depolarizing pulse to +40 mV. The IC50 value for the sibutramine block of Kv4.3 was 17.3 microM. Under control conditions, the inactivation of Kv4.3 currents could be fit to a biexponential function, and the time constants for the fast and slow components were significantly decreased after the application of sibutramine. The association (k+1) and dissociation (k-1) rate constants for the sibutramine block of Kv 4.3 were 1.51 microM-1s-1 and 27.35 s-1, respectively. The theoretical KD value, derived from k-1/k+1, yielded a value of 18.11 microM. The block of Kv4.3 by sibutramine displayed a weak voltage dependence, increasing at more positive potentials, and it was use-dependent at 2 Hz. Sibutramine did not affect the time course for the deactivating tail currents. Neither steady-state activation and inactivation nor the recovery from inactivation was affected by sibutramine. Sibutramine caused the concentration-dependent block of the Kv1.3 and Kv3.1 currents with an IC50 value of 3.7 and 32.7 microM, respectively. In addition, sibutramine reduced the tail current amplitude and slowed the deactivation of the tail currents of Kv1.3 and Kv3.1, resulting in a crossover phenomenon. These results indicate that sibutramine acts on Kv4.3, Kv1.3, and Kv3.1 as an open channel blocker.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17312186     DOI: 10.1124/jpet.106.117747

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  6 in total

1.  Rosiglitazone inhibits Kv4.3 potassium channels by open-channel block and acceleration of closed-state inactivation.

Authors:  I Jeong; B H Choi; S J Hahn
Journal:  Br J Pharmacol       Date:  2011-06       Impact factor: 8.739

2.  Inhibition of Kv4.3 by genistein via a tyrosine phosphorylation-independent mechanism.

Authors:  Hee Jae Kim; Hye Sook Ahn; Bok Hee Choi; Sang June Hahn
Journal:  Am J Physiol Cell Physiol       Date:  2010-12-09       Impact factor: 4.249

3.  Assessment of redox state and biochemical parameters of salivary glands in rats treated with anti-obesity drug sibutramine hydrochloride.

Authors:  Damáris Raissa Dos Santos; Gabriela Alice Fiais; Henrique Arnaldo Oliveira; Tayná Buffulin Ribas; Rayne Oliveira Souza; Thaís Verônica Saori Tsosura; Doris Hissako Matsushita; Edilson Ervolino; Rita Cássia Menegati Dornelles; Ana Cláudia de Melo Stevanato Nakamune; Antonio Hernandes Chaves-Neto
Journal:  Clin Oral Investig       Date:  2022-05-13       Impact factor: 3.606

4.  Electrical remodelling maintains firing properties in cortical pyramidal neurons lacking KCND2-encoded A-type K+ currents.

Authors:  Jeanne M Nerbonne; Benjamin R Gerber; Aaron Norris; Andreas Burkhalter
Journal:  J Physiol       Date:  2008-01-10       Impact factor: 5.182

Review 5.  Regulation of Intestinal Glucose Absorption by Ion Channels and Transporters.

Authors:  Lihong Chen; Biguang Tuo; Hui Dong
Journal:  Nutrients       Date:  2016-01-14       Impact factor: 5.717

6.  Slimmer or fertile? Pharmacological mechanisms involved in reduced sperm quality and fertility in rats exposed to the anorexigen sibutramine.

Authors:  Cibele S Borges; Gabriela Missassi; Enio S A Pacini; Luiz Ricardo A Kiguti; Marciana Sanabria; Raquel F Silva; Thais P Banzato; Juliana E Perobelli; André S Pupo; Wilma G Kempinas
Journal:  PLoS One       Date:  2013-06-12       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.